Loading...
Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators
The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is the largest study of cardiovascular disease in human immunodeficiency virus. Enrolling 7770 participants from 2015 to 2019 with sites across 5 continents, REPRIEVE will assess the effects of a statin as a cardiovascular disease pre...
Na minha lista:
| Udgivet i: | J Infect Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7347079/ https://ncbi.nlm.nih.gov/pubmed/32645161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa098 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|